{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:23:41Z","timestamp":1763141021306,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"am","delay-in-days":292,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"publisher","award":["1R21 DE025933"],"award-info":[{"award-number":["1R21 DE025933"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007710","name":"University of Connecticut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.bone.2018.03.009","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T14:18:20Z","timestamp":1520605100000},"page":"28-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Rescue of a cherubism bone marrow stromal culture phenotype by reducing TGF\u03b2 signaling"],"prefix":"10.1016","volume":"111","author":[{"given":"Yaling","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst","family":"Reichenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyoshi","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumna","family":"Arif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0098-4399","authenticated-orcid":false,"given":"Peter","family":"Maye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.bone.2018.03.009_bb0005","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1750-1172-7-S1-S6","article-title":"Cherubism: best clinical practice","volume":"7","author":"Papadaki","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2018.03.009_bb0010","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1750-1172-7-S1-S5","article-title":"The role of SH3BP2 in the pathophysiology of cherubism","volume":"7","author":"Reichenberger","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.bone.2018.03.009_bb0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/01.sap.0000248141.36904.19","article-title":"Two-stage surgical treatment of severe cherubism","volume":"58","author":"Raposo-Amaral","year":"2007","journal-title":"Ann. Plast. Surg."},{"issue":"2","key":"10.1016\/j.bone.2018.03.009_bb0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/88832","article-title":"Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism","volume":"28","author":"Ueki","year":"2001","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bone.2018.03.009_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cell.2006.10.047","article-title":"Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 \u201ccherubism\u201d mice","volume":"128","author":"Ueki","year":"2007","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bone.2018.03.009_bb0030","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2011.10.045","article-title":"Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism","volume":"147","author":"Levaot","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bone.2018.03.009_bb0035","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.cell.2011.10.046","article-title":"Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease","volume":"147","author":"Guettler","year":"2011","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bone.2018.03.009_bb0040","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis\u2014a common pathway to organ injury and failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1\u20132","key":"10.1016\/j.bone.2018.03.009_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1083\/jcb.132.1.195","article-title":"Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype","volume":"132","author":"Erlebacher","year":"1996","journal-title":"J. Cell Biol."},{"issue":"7","key":"10.1016\/j.bone.2018.03.009_bb0050","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1091\/mbc.9.7.1903","article-title":"Osteoblastic responses to TGF-beta during bone remodeling","volume":"9","author":"Erlebacher","year":"1998","journal-title":"Mol. Biol. Cell"},{"issue":"19","key":"10.1016\/j.bone.2018.03.009_bb0055","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1242\/dev.126.19.4267","article-title":"Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass","volume":"126","author":"Filvaroff","year":"1999","journal-title":"Development"},{"issue":"9","key":"10.1016\/j.bone.2018.03.009_bb0060","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1093\/emboj\/20.9.2254","article-title":"TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation","volume":"20","author":"Alliston","year":"2001","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.bone.2018.03.009_bb0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jcp.20036","article-title":"Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation","volume":"200","author":"Karst","year":"2004","journal-title":"J. Cell. Physiol."},{"issue":"15","key":"10.1016\/j.bone.2018.03.009_bb0070","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1016\/j.yexcr.2008.06.006","article-title":"TGF-beta coordinately activates TAK1\/MEK\/AKT\/NFkB and SMAD pathways to promote osteoclast survival","volume":"314","author":"Gingery","year":"2008","journal-title":"Exp. Cell Res."},{"issue":"4","key":"10.1016\/j.bone.2018.03.009_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005275","article-title":"Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone","volume":"4","author":"Mohammad","year":"2009","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bone.2018.03.009_bb0080","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/jbmr.139","article-title":"Inhibition of TGF-beta signaling by 1D11 antibody treatment increases bone mass and quality in vivo","volume":"25","author":"Edwards","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bone.2018.03.009_bb0085","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1359\/jbmr.2001.16.7.1228","article-title":"Col1a1-driven transgenic markers of osteoblast lineage progression","volume":"16","author":"Dacic","year":"2001","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2018.03.009_bb0090","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/jcb.10459","article-title":"Stage specific inhibition of osteoblast lineage differentiation by FGF2 and noggin","volume":"88","author":"Kalajzic","year":"2003","journal-title":"J. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.bone.2018.03.009_bb0095","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1172\/JCI112202","article-title":"Human transforming growth factor-alpha stimulates bone resorption in vitro","volume":"76","author":"Stern","year":"1985","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.bone.2018.03.009_bb0100","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1073\/pnas.83.7.2228","article-title":"Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro","volume":"83","author":"Ibbotson","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bone.2018.03.009_bb0105","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1124\/mol.65.3.744","article-title":"SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7","volume":"65","author":"DaCosta Byfield","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"5155","key":"10.1016\/j.bone.2018.03.009_bb0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1126\/science.8140412","article-title":"Characterization of type I receptors for transforming growth factor-beta and activin","volume":"264","author":"ten Dijke","year":"1994","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bone.2018.03.009_bb0115","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1128\/MCB.16.3.1066","article-title":"Activation of signalling by the activin receptor complex","volume":"16","author":"Attisano","year":"1996","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.bone.2018.03.009_bb0120","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1210\/me.2003-0393","article-title":"Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5","volume":"18","author":"Mazerbourg","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bone.2018.03.009_bb0125","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mce.2015.01.036","article-title":"Growth differentiation factor 8 down-regulates pentraxin 3 in human granulosa cells","volume":"404","author":"Chang","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"7","key":"10.1016\/j.bone.2018.03.009_bb0130","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.bone.2018.03.009_bb0135","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/jbmr.2120","article-title":"Role of TGF-beta in a mouse model of high turnover renal osteodystrophy","volume":"29","author":"Liu","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bone.2018.03.009_bb0140","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/jbmr.357","article-title":"Regulation of RANKL-induced osteoclastogenesis by TGF-beta through molecular interaction between Smad3 and Traf6","volume":"26","author":"Yasui","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2018.03.009_bb0145","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/jbmr.2418","article-title":"Genomewide comprehensive analysis reveals critical cooperation between Smad and c-Fos in RANKL-induced osteoclastogenesis","volume":"30","author":"Omata","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.bone.2018.03.009_bb0150","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1172\/JCI118966","article-title":"Mysterious cross talk between bone cells","volume":"98","author":"Lian","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bone.2018.03.009_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1016-8478(23)12997-9","article-title":"Osteoimmunology: interactions of the immune and skeletal systems","volume":"17","author":"Rho","year":"2004","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.bone.2018.03.009_bb0160","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MNH.0b013e32832b75f1","article-title":"Cross-talk among bone cells","volume":"18","author":"Matsuo","year":"2009","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"1","key":"10.1016\/j.bone.2018.03.009_bb0165","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bone.2012.10.003","article-title":"Anti-tumor necrosis factor treatment in cherubism\u2014clinical, radiological and histological findings in two children","volume":"52","author":"Hero","year":"2013","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2018.03.009_bb0170","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/jbmr.2125","article-title":"Etanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-alpha-induced inflammation and bone loss","volume":"29","author":"Yoshitaka","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2018.03.009_bb0175","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nm.3544","article-title":"Excessive transforming growth factor-beta signaling is a common mechanism in osteogenesis imperfecta","volume":"20","author":"Grafe","year":"2014","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.bone.2018.03.009_bb0180","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/jbmr.1992","article-title":"Hyperactive transforming growth factor-beta1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model","volume":"28","author":"Rhodes","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/j.bone.2018.03.009_bb0185","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1172\/JCI39845","article-title":"Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice","volume":"119","author":"Heydemann","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.bone.2018.03.009_bb0190","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGFbeta signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218301169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218301169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:40:33Z","timestamp":1757612433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328218301169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":38,"alternative-id":["S8756328218301169"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2018.03.009","relation":{},"ISSN":["8756-3282"],"issn-type":[{"type":"print","value":"8756-3282"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rescue of a cherubism bone marrow stromal culture phenotype by reducing TGF\u03b2 signaling","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2018.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}